Fortress Biotech, Inc. 8-K

What Happened
Fortress Biotech, Inc. (FBIO) announced a corporate update and reported its financial results for the quarter ended March 31, 2026 via a press release dated May 14, 2026. The company furnished the press release as Exhibit 99.1 to its Form 8-K filed May 14, 2026.

Key Details

• Filing date: May 14, 2026; press release furnished as Exhibit 99.1.
• Reporting period: quarter ended March 31, 2026 (quarterly results/earnings announced).
• The information (including Exhibit 99.1) is furnished, not “filed,” under the Exchange Act (limits Section 18 liability and incorporation by reference).
• Form 8-K signed by David Jin, Chief Financial Officer, on May 14, 2026.

Why It Matters
This 8-K signals that Fortress has released its latest quarterly results and a corporate update; investors should read the furnished press release (Exhibit 99.1) for revenue, earnings, cash position, and any operational or guidance changes. Because the release is furnished rather than filed, the company is providing the information to the market but with more limited legal liability under the Exchange Act. Check the press release and subsequent SEC filings for the detailed financial figures and any follow-up disclosures.